EDETEK Unveils R&D Cloud for Clinical Development

Siarhei | AdobeStock_408552325

The digital transformation of the pharmaceutical industry continues to provide innovative ways to improve the clinical research process. With the growing importance of strategies like real-time data capturing and analysis, utilizing technology like AI and machine learning continues to help not only automate the collection and monitoring of data but ultimately shorten the timeline of clinical trials.

EDETEK Inc., a digital clinical platform company, announced the launch of R&D Cloud, a software ecosystem that addresses these issues.

Built upon the company’s core platforms, CONFORM™ and eClinical, R&D Cloud is a versatile solution that users can alter to fit a specific study’s needs from start to finish. Customization options include integrating third-party products and picking selected services that fit the trial. Options are made in the cloud’s secure multi-SSO workflow and is available both internally and externally for stakeholder use.

"The launch of our R&D Cloud exemplifies EDETEK's dedication to innovation and delivering superior solutions," EDETEK CEO Jian Chen said in a press release. "This platform…integrates a comprehensive suite of capabilities from our CONFORM™ platform, including near-real-time data collection, comprehensive data cleansing, monitoring and review, automated regulatory dataset generation, and sophisticated visualization and analytics. It also integrates with our eClinical platform encompassing Clinical Trial Management System (CTMS), Electronic Data Capture (EDC), Randomization and Trial Supply Management (RTSM), ePayments, eConsent, PV/Safety, and Electronic Patient Reported Outcome (ePRO). This ensures we not only address the current demands of the life sciences industry but also proactively anticipate and prepare for future challenges and opportunities."¹ R&D Cloud is designed to be able to easily integrate into the client’s existing operational environment.

In the same press release, Dr. Shakthi Kumar, chief strategy & business officer, added, “By effortlessly integrating cutting-edge data management and workflow solutions alongside our therapeutic-specific accelerators, we empower our clients to conduct clinical trials with unprecedented efficiency and precision. Recognizing the diverse needs of our clients, we offer the flexibility to build a tailor-made R&D Cloud environment."¹

"Integrated cloud-based clinical trial solutions to date have offered the promise of efficient dataflow but with the drawback of compromising on individual best-in-class tools," leading independent clinical advisor, Craig Lipset, added. "The EDETEK R&D Cloud offers the best of both worlds by adding flexibility, allowing life sciences organizations to have the benefits of an integrated platform while selecting the components that are optimal for their organization. Sponsors and CROs no longer have to compromise to have the benefits of integration." ¹

EDETEK launched CONFORM™ - ONCO+ in late October 2024. The clinical platform is a therapeutic area-specific accelerator designed to streamline data collection and integration.²

References

1. EDETEK Unveils Revolutionary Life Sciences R&D Cloud for Clinical Development. EDETEK. January 13, 2025. https://www.prnewswire.com/news-releases/edetek-unveils-revolutionary-life-sciences-rd-cloud-for-clinical-development-302348866.html
2. EDETEK Launches CONFORM™ - ONCO+, a Therapeutic Area-Specific Accelerator for the CONFORM™ Platform. EDETEK. October 23, 2024. Accessed January 13, 2025. https://www.prnewswire.com/news-releases/edetek-launches-conform---onco-a-therapeutic-area-specific-accelerator-for-the-conform-platform-302284254.html